Periodic Safety Update Report system draws varying reactions

Published: 2010-07-27 07:00:00

Updated: 2010-07-27 07:00:00

Pharmaceutical companies have disclosed varying views with reference to Periodic Safety Update Reports (PSUR) the Korea Food and Drug Administration aims to introduce as part of its efforts to provide an update of the worldwide safety experience of a medicinal product to competent authorities at ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK